NRX Pharmaceuticals, Inc.
NRXP • NASDAQ • Stock Fundamentals
NRX Pharmaceuticals, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Jonathan C. Javitt, with a market cap of $156.1M.
Market Cap$156.1M
CEOJonathan C. Javitt
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 15, 2026 · 13 days agoQ1 2026
View reportNext EarningsAug 17, 2026 · in 3 monthsQ2 2026
Financials
Based on Q1 2026 filing
NRX Pharmaceuticals, Inc. FAQ
Common questions about NRX Pharmaceuticals, Inc.
NRX Pharmaceuticals, Inc. (NRXP) has a market capitalization of $156.1M and trades on NASDAQ.